The Discounted Cash Flow (DCF) valuation of CureVac NV (CVAC) is (41.60) USD. With the latest stock price at 3.16 USD, the upside of CureVac NV based on DCF is -1416.3%.
Note: valuation result may not be accurate due to the company's negative cashflows.
Range | Selected | |
WACC / Discount Rate | 7.9% - 10.6% | 9.3% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (75.29) - (28.79) | (41.60) |
Upside | -2482.5% - -1011.0% | -1416.3% |